Menu
← Oncology Approval Tracker
FDA DECISION ·
Rylaze
asparaginase erwinia chrysanthemi (recombinant)-rywn · Jazz Pharmaceuticals
Open LinkedIn brief ↓1 min read · estimated
APPROVED USE
What FDA approved
Adds an intramuscular Monday/Wednesday/Friday schedule in multiagent treatment of ALL or lymphoblastic lymphoma from age one month after hypersensitivity to E. coli-derived asparaginase.
LAMPGEN ANALYSIS
Why it matters
The alternate schedule changes administration timing while serving the established substitution population.
What research teams should watch
Plan the Monday and Wednesday doses and the larger Friday dose around the longer weekend interval.
PRIMARY RECORDS